Cargando…

CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS

PURPOSE: To evaluate the clinical features of Type 1 idiopathic macular telangiectasia (IMT) followed up for 2 years. METHODS: Forty-nine patients with unilateral Type 1 IMT were examined. Thirty-one IMT eyes were treated with direct laser photocoagulation and/or intravitreal bevacizumab; the remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osaka, Rie, Shiragami, Chieko, Ono, Aoi, Kobayashi, Mamoru, Takasago, Yukari, Yamashita, Ayana, Tsujikawa, Akitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Retina 2018
Materias:	Original Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753814/ https://www.ncbi.nlm.nih.gov/pubmed/28541960 http://dx.doi.org/10.1097/IAE.0000000000001724

Ejemplares similares

MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION
por: Takasago, Yukari, et al.
Publicado: (2019)

One-year outcomes of fixed treatment of intravitreal aflibercept for exudative age-related macular degeneration and the factor of visual prognosis
por: Ono, Aoi, et al.
Publicado: (2018)

The effect of vitreomacular and cataract surgery on oxygen saturation in retinal vessels
por: Nakano, Yuki, et al.
Publicado: (2017)

Metamorphopsia associated with central retinal vein occlusion
por: Manabe, Koichiro, et al.
Publicado: (2017)

Persistent metamorphopsia associated with branch retinal vein occlusion
por: Osaka, Rie, et al.
Publicado: (2018)

Effect of Switching Therapy to Pegaptanib in Eyes With the Persistent Cases of Exudative Age-Related Macular Degeneration
por: Shiragami, Chieko, et al.
Publicado: (2014)

Effect of topical isopropyl unoprostone on macular atrophy progression in eyes with exudative age-related macular degeneration
por: Shiragami, Chieko, et al.
Publicado: (2017)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Retinal Oximetry in a Healthy Japanese Population
por: Nakano, Yuki, et al.
Publicado: (2016)

Correlations among age, sex, axial length, and subfoveal choroidal thickness in the choriocapillaris structure analyzed using multiple en face image averaging optical coherence tomography angiography
por: Ichioka, Ai, et al.
Publicado: (2021)

Metamorphopsia Associated with Branch Retinal Vein Occlusion
por: Manabe, Koichiro, et al.
Publicado: (2016)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban, Abdallah A, et al.
Publicado: (2012)

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization
por: Çoban Karataş, Müge, et al.
Publicado: (2022)

The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients
por: Murata, Toshinori, et al.
Publicado: (2021)

Author Correction: The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment‑naïve patients
por: Murata, Toshinori, et al.
Publicado: (2021)

Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
por: Nishikawa, Keiichi, et al.
Publicado: (2019)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
por: Shanmugam, Mahesh P, et al.
Publicado: (2007)

Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival
por: Takasago, Yukari, et al.
Publicado: (2018)

Choroidal vascularity index change in macular telangiectasia type 2
por: Chun, Heejeong, et al.
Publicado: (2022)

Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
por: Tilleul, Julien, et al.
Publicado: (2014)

Estimating ranibizumab injection numbers and visual acuity at 12 months based on 2-month data on branch retinal vein occlusion treatment
por: Murata, Toshinori, et al.
Publicado: (2022)

Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2
por: Chandran, Kiran, et al.
Publicado: (2023)

Closure of Recalcitrant Macular Hole after Choroidal Neovascularization
por: Ilhan, Cagri, et al.
Publicado: (2022)

Choroidal Neovascularization Associated with Best Vitelliform Macular Dystrophy
por: Adiyeke, Seda Karaca, et al.
Publicado: (2022)

Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor
por: Shah, Shreyas, et al.
Publicado: (2023)

Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
por: Arrigo, Alessandro, et al.
Publicado: (2021)

Progression of subclinical choroidal neovascularization in age-related macular degeneration
por: Heiferman, Michael J., et al.
Publicado: (2019)

Choroidal ischemia drives macular neovascularization in persistent placoid maculopathy
por: Fogel Levin, Meira, et al.
Publicado: (2022)

Choroidal and Retinal Imaging Biomarkers in Different Types of Macular Neovascularization
por: Toto, Lisa, et al.
Publicado: (2023)

POLYPOIDAL CHOROIDAL NEOVASCULARIZATION VERSUS TYPE 1 CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: A Fractal Analysis Study
por: Serra, Rita, et al.
Publicado: (2022)

Pemafibrate prevents choroidal neovascularization in a mouse model of neovascular age-related macular degeneration
por: Lee, Deokho, et al.
Publicado: (2023)

Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2 with Associated Subretinal Neovascular Membrane
por: Villegas, Victor M., et al.
Publicado: (2017)

Choroidal endothelial and macrophage gene expression in atrophic and neovascular macular degeneration
por: Voigt, Andrew P, et al.
Publicado: (2022)

Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration
por: Miyata, Manabu, et al.
Publicado: (2021)

Development of focal choroidal excavation in non-neovascular age related macular degeneration with pachy-choroid features
por: Banaee, Touka, et al.
Publicado: (2019)

Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization
por: Gao, Rui, et al.
Publicado: (2021)

Different treatment modalities for choroidal neovascularization in two eyes of one patient with bilateral type 2A parafoveal telangiectasia
por: Dave, Vivek, et al.
Publicado: (2013)

ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization
por: Qin, Yu, et al.
Publicado: (2022)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2010)

Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
por: Ladas, Ioannis D, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rvnij8vldk82t0slqrpblt1mgb